Regulatory Open Forum

 View Only
  • 1.  ARs, NBs, and classification review

    This message was posted by a user wishing to remain anonymous
    Posted 18-Feb-2020 16:57
    This message was posted by a user wishing to remain anonymous

    Hello,

    I work at a startup with a novel device for which classification review is a high priority. We recently secured a Notified Body. One of our partners involved in our development process is adamant that we need to secure an Authorized Representative (AR) right away. They say that ARs can represent us (the manufacturer) to the Competent Authority for classification review. In my experience, ARs typically provide post-market support mainly around vigilance, incident reporting, recalls/FSCAs, etc. I know they can provide extra services such as labeling review, standards compliance guidance, etc, but I have never heard of (or seen any written material) regarding an AR assisting with manufacturer representation for classification review. I thought that NBs were the primary partner for premarket activities in the EU.

    Questions:
    1. Is it true that ARs can represent manufacturers to the CA (and that this is beneficial for the manufacturer)?

    2. What are best practices for how to prepare for the NB classification review for a novel device? We have not yet received specific guidance from the NB on the exact process. We have an upcoming meeting scheduled with the Technical Rep. but it would be good to get feedback on this forum as well.

    Thank you.



  • 2.  RE: ARs, NBs, and classification review

    Posted 19-Feb-2020 04:20
    Hi Anon.

    First of all, it is you, as the manufacturer, who determines the classification of your device, based on the classification rules in the MDD or MDR, as applicable. Your NB will review your justification for the classification and if they have a different opinion, will propose an alternative classification. If you and the NB cannot agree on a classification, then you may refer this to the CA for a decision. 

    With regard to ARs representing the manufacturer in front of the CA, yes, this can be useful sometimes, but it depends on the experience and expertise of the AR. The AR may be able to add specific European regulatory expertise to the technical expertise of the manufacturer, but identifying an AR early in the CE marking process is not mandatory.

    Hope this is useful.

    As mentioned above, best practice for your technical documentation is to include specific sections, firstly justifying your product as a medical device, and secondly justifying your classification conclusion based on the classification rules.

    ------------------------------
    Roger Gray
    VP Quality and Regulatory
    Donawa Lifescience Consulting
    Clinical Studies - Regulatory - Quality Systems
    Rome, Italy
    +39 06 578 2665
    rgray@donawa.com
    www.donawa.com
    ------------------------------



  • 3.  RE: ARs, NBs, and classification review

    Posted 19-Feb-2020 04:37
    Good day,

    To answer your questions:
    1. Yes, an AR can represent you as a company to a Competent Authority - though they should have the regulatory knowledge, experience with your device, and understand the situation including any classification rationales.  An AR can be the liaison between ​the Manufacturer and the Competent Authority in matters of post market, requests for technical documentation information, and other regulatory assistance.  But you are right an AR typically acts more in a post market role than a premarket role.  Though you as the Manufacturer can work with a Competent Authority directly, you do not need to go through an AR.  In fact, in cases of classification where the Notified Body can not assist, then it may be beneficial to go directly to a Competent Authority.
    2. I am not sure you will find specific guidance from an NB on exact process of classification.  I have never seen one.  Though we have a nice supposed process as part of the new EU MDR where the MDCG group will help coordinate regulatory status and classification of products (including so-called borderline products) through Expert Panels and technical working groups.  Logically the process should be confirm with Notified Body first on classification, then either they (the NB) or you escalate to a Competent Authority.  The EU MDR should make this process more distinct, but there is not yet any guidance on this process.  In the future, it should go NB, then CA, then MDCG, then Expert Panel, then maybe technical working group, back to Expert Panel, back to MDCG, back to CA, back to NB, back to Manufacturer.  In the end, depending on the novelty of the device, there might even be a new Common Specification.  And as you can imagine this process is going to take a long time - so good luck getting new, novel devices on the market in the EU.  Also a comment: do not ask the NB/CA what is the classification.  Go to them with a clear regulatory strategy for your device including classification and rationale behind your justification for classification including Rule.  What you want to achieve is them agreeing with your approach.

    ------------------------------
    Richard Vincins RAC
    Vice President Global Regulatory Affairs
    ------------------------------



  • 4.  RE: ARs, NBs, and classification review

    Posted 19-Feb-2020 06:40
    Hi Anon,

    Your instincts are correct, at least in my experience.  A CE AR is not going to be your advocate with a Competent Authority.  Your best approach is to work with your NB with regards to classification, and then resort to the CA if you reach an impasse.  The AR may be a venue to facilitate contact with the CA, but do not expect them to do much beyond that.

    James

    ------------------------------
    James Bonds J.D.
    Director Regulatory Affairs
    Atlanta GA
    United States
    ------------------------------



  • 5.  RE: ARs, NBs, and classification review

    This message was posted by a user wishing to remain anonymous
    Posted 20-Feb-2020 17:03
    This message was posted by a user wishing to remain anonymous

    Thank you everyone. Your responses were very helpful on both points.